Advanced Search

 

Study ID Status Title Patient Level Data
105816 Completed A post-marketing surveillance to monitor the safety of 3TCTM (Lamivudine 150mg) administered in Korean subjects according to the prescribing information
105817 Completed A post-marketing surveillance study to monitor the safety of Imigran (sumatriptan) administered in Korean subjects according to the prescribing information.
105818 Completed A post-marketing surveillance (PMS) study to monitor the safety of Naramig (Naratriptan) administered in Korean subjects according to the prescribing information.
105822 Completed A Single-Blind, Randomised, Placebo-Controlled Study to Evaluate the Effect of Repeated Dosing of an Investigational Product on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Adult Subjects.
105874 Completed Bridging Safety & Immunogenicity study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years Study Listed on ClinicalStudyDataRequest.com
105908 Completed Comparative study evaluating the immunogenicity and safety of MeMuRu-OKA vaccine and measles-mumps-rubella vaccine (Priorix™) co-administered with varicella vaccine (Varilrix™) in children primed with measles-mumps-rubella vaccine Study Listed on ClinicalStudyDataRequest.com
105909 Completed Comparative study evaluating the immunogenicity & safety of MeMuRu-OKA vaccine & measles-mumps-rubella vaccine (Priorix™) co-administered with varicella vaccine (Varilrix™) in children primed with both measles-mumps-rubella & varicella vaccines Study Listed on ClinicalStudyDataRequest.com
105910 Completed Compare immunogenicity & reactogenicity of 2 formulations of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (new vs current) given in healthy infants. The DTPa-HBV-IPV vaccine (new formulation) will also be assessed in a 3rd group of subjects Study Listed on ClinicalStudyDataRequest.com
105926 Completed Phase 3, open, age-stratified study to assess immunogenicity and safety of GSK Biologicals' HPV-16/18 vaccine administered intramuscularly according to 3-dose schedule (0,1,6 months) in healthy female subjects aged 15 - 55 years and long term follow-up Study Listed on ClinicalStudyDataRequest.com
105934 Completed A Post-Marketing Surveillance to monitor the safety of Relenza (Zamamivir) adminstered in Korean subjects according to the prescribing information
105935 Completed A Post-Marketing Surveillance to monitor the safety of PritorPlusTM (telmisartan/hydrochlorothiazide) administered in Korean subjects according to the prescribing information
105936 Completed A Post Marketing Surveillance to monitor the safety of ULTIVA (Remifentanil) adminstered in Korean subjects according to the prescribing information
105937 Completed A post-marketing surveillance to monitor the safety of Vaxar (Lacidipine) administered in Korean subjects according to the prescribing information
105987 Completed A single-blind, randomized, controlled, multinational study for the evaluation of safety of GlaxoSmithKline (GSK) Biologicals’ investigational vaccination regimen compared to monovalent Haemophilus influenzae type b (Hib) control vaccine in healthy infants at 2, 4, 6, and 12 to 15 months of age. Study Listed on ClinicalStudyDataRequest.com
106001 Completed A phase III, double-blind, randomized, controlled study to evaluate immunogenicity and safety of GSK Biologicals’ HPV-16/18 L1 VLP AS04 vaccine, administered intramuscularly (0, 1, 6 month schedule) in healthy females aged 18 – 35 years Study Listed on ClinicalStudyDataRequest.com
106006 Completed A Randomised, Single-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics and Pharmacodynamics of Intravenous Infusion of GSK933776 in Patients with Alzheimer's Disease. Study Listed on ClinicalStudyDataRequest.com
106066 Completed Clinical Evaluation of ropinirole PR/XR Tablet for Adjunctive Therapy to L-dopa in subjects with advanced Parkinson’s disease Study Listed on ClinicalStudyDataRequest.com
106068 Completed A phase I/II, randomized, observer blinded study to evaluate and compare the safety, reactogenicity and immunogenicity of GlaxoSmithKline Biologicals’ investigational pneumococcal vaccine formulations versus a licensed non-GlaxoSmithKline Biologicals’ vaccine and GlaxoSmithKline Biologicals’ aluminum-based 10-valent pneumococcal conjugate vaccine, in healthy elderly subjects Study Listed on ClinicalStudyDataRequest.com
106069 Completed Study to assess the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV vaccine GSK580299 in healthy female subjects aged 10-25 years Study Listed on ClinicalStudyDataRequest.com
106101 Completed An Observational Study of the Adherence Behaviour of Individuals Travelling to Chloroquine Resistant Plasmodium Falciparum Malarious Zones Taking Anti-Malarial Medication Study Listed on ClinicalStudyDataRequest.com
106128 Completed A double-blind, randomised, two-period, crossover drug interaction study to investigate the pharmacokinetic and pharmacodynamic effects of 7 days co-administration of salmeterol (50 mcg bid) with ketoconazole (400 mg od). Study Listed on ClinicalStudyDataRequest.com
106139 Completed A Six-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy, Safety, and Tolerability of GSK561679 Compared to Placebo in Female Subjects, Diagnosed with Major Depressive Disorder
106181 Completed An open-label, single-arm study to determine the excretionbalance and metabolic disposition of [14C]GW642444administered as a single dose of an oral solution to healthy malevolunteers Study Listed on ClinicalStudyDataRequest.com
106206 Completed Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in the Treatment of Acute Pulmonary Thromboembolism (PE) Study Listed on ClinicalStudyDataRequest.com
106207 Completed An open-label, multi-centre, observational, post-marketing surveillance to monitor the safety of REQUIP(ropinirole) administered in Korean restless leg syndrome patients according to the prescribing information

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.